TUBO Mammary Adenocarcinoma: Sensitivity to α-neu Antibody Treatment

DESCRIPTION

This study investigates the sensitivity of TUBO mammary adenocarcinoma to α-neu antibody (Ab). We present data on untreated TUBO tumor volume (mm3) and corresponding α-neu IgG concentrations (Ab4 equivalent μg/mL). The experimental scheme included BALB/c female mice vaccinated with pNeuE2 on days 0 and 2 (n=4). The results shown are representative of three independent experiments, highlighting the potential of α-neu antibodies as a therapeutic approach in TUBO tumors.

Download

1 / 1

Mar 18, 2014

Télécharger la présentation

TUBO Mammary Adenocarcinoma: Sensitivity to α-neu Antibody Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

A B Figure S1. TUBO mammary adenocarcinoma is highly sensitive to α-neu Ab. (A) Untreated TUBO - tumor volume (mm3) and α-neu IgG (Ab4 equivalent μg/mL) are plotted on the left and right y-axis respectively. (B) Experimental Scheme - BALB/c females were vaccinated with pNeuE2 on day 0 and 2 (n= 4). Data representative of three independent experiments.

More Related